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Abstract
Furin, a specialized endoproteinase, transforms proproteins into biologically active proteins. Furin function is important for
normal cells and also in multiple pathologies including malignancy and anthrax. Furin is believed to cycle between the Golgi
compartment and the cell surface. Processing of anthrax protective antigen-83 (PA83) by the cells is considered thus far as
evidence for the presence of substantial levels of cell-surface furin. To monitor furin, we designed a cleavage-activated FRET
biosensor in which the Enhanced Cyan and Yellow Fluorescent Proteins were linked by the peptide sequence
SNSRKKRQSTSAGP derived from anthrax PA83. Both because of the sensitivity and selectivity of the anthrax sequence to
furin proteolysis and the FRET-based detection, the biosensor recorded the femtomolar levels of furin in the in vitro
reactions and cell-based assays. Using the biosensor that was cell-impermeable because of its size and also by other
relevant methods, we determined that exceedingly low levels, if any, of cell-surface furin are present in the intact cells and in
the cells with the enforced furin overexpression. This observation was in a sharp contrast with the existing concepts about
the furin presentation on cell surfaces and anthrax disease mechanism. We next demonstrated using cell-based tests that
PA83, in fact, was processed by furin in the extracellular milieu and that only then the resulting PA63 bound the anthrax
toxin cell-surface receptors. We also determined that the biosensor, but not the conventional peptide substrates, allowed
continuous monitoring of furin activity in cancer cell extracts. Our results suggest that there are no physiologically-relevant
levels of cell-surface furin and, accordingly, that the mechanisms of anthrax should be re-investigated. In addition, the
availability of the biosensor is a foundation for non-invasive monitoring of furin activity in cancer cells. Conceptually, the
biosensor we developed may serve as a prototype for other proteinase-activated biosensors.
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Introduction
FRET takes place between a donor and acceptor fluorophore
moieties if there is an overlap between the emission spectrum of
the donor and the absorption spectrum of the acceptor [1]. In
addition to this spectral overlap, the two fluorophores must be
properly aligned within a certain distance of each other. There is a
close relationship between donor-acceptor distance and efficiency
of energy transfer [2,3,4]. If the donor and the acceptor are linked
by a peptide sequence that spans a proteinase cleavage site,
following proteolytic cleavage the donor and the acceptor are
separated and are no longer in close proximity. As a result, the
level of FRET rapidly and significantly decreases. FRET can be
quantified according to a ratio of light emission at the two specific
wavelengths which are unique for the donor and the acceptor.
These parameters stimulate the use of FRET-based biosensors as
the molecular tools in the proteinase research [5,6,7,8,9,10,11,12].
Multiple cellular proteins including growth factors, hormones,
metalloproteinases and cell receptors are synthesized as inactive
precursors [13,14]. These precursors are transformed into
functionally active proteins by the cleavage action of proprotein
convertases (PCs), specialized serine endoproteinases with the
focused cleavage preferences [15,16]. Seven PCs (furin, PACE4,
PC1/3, PC2, PC4, PC5/6, and PC7) have been identified in
humans [17]. Furin and other PCs cleave the multibasic motifs
Arg-Xxx-Arg/Lys/Xxx-ArgQ, and thus transform proproteins
into biologically active proteins and peptides [18,19,20,21]. Furin
is currently the most studied enzyme of the PC family. Furin is
activated autocatalytically [21]. The autoactivated furin then
cleaves latent precursors in the Golgi and the secretory vesicles,
and, potentially, also at the cell membrane, post-secretion. In
addition to normal cell functions, furin is implicated in many
pathogenic states, because it processes to maturity membrane
fusion proteins and pro-toxins of a variety of both bacteria and
viruses, including anthrax toxin.
Anthrax toxin includes protective antigen and edema and lethal
factors (EF and LF, respectively) [22,23]. It has been suggested
that during the process of intoxication, the 83 kDa protective
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receptors. Two receptor types are a capillary morphogenesis
protein 2 (CMG2) that is the major receptor mediating lethality of
anthrax toxin in vivo and the anthrax toxin receptor/tumor
endothelial marker 8 (ATR/TEM8) that plays a minor role.
CMG2 is expressed in most human tissues. The expression of
TEM8 is restricted to tumor endothelium and cancer cells [24].
The receptor-bound PA83 is believed to be then cleaved by
cellular furin and related PCs [25,26]. This cleavage releases a
20 kDa N-terminal fragment and a cell-bound, C-terminal 63 kDa
protein (PA63). The latter oligomerizes into a ring-shaped PA
heptamer that exposes the binding sites for EF and LF [27,28].
The functional heptamer, however, may include both PA63 and
PA83 [29]. The N-terminal ends of both EF and LF bind to PA63.
The respective C-terminal parts of EF and LF exhibit the
adenylate cyclase and the metalloproteinase activity, respectively.
A complex formed by the PA63 heptamer and either EF or LF or
both is internalized into the cell by receptor-mediated, clathrin-
dependent, endocytosis [30]. In the acidified lumen of the
endosomes, the heptamer forms a channel through which EF
and LF are transported from the endosomal compartment into the
cytoplasm of the host cell. In the cytoplasm, EF and LF produce
their toxic effects.
To analyze the role of furin in the PA83 processing in more
detail and to develop a specific biosensor for furin–like PC activity,
we have specifically selected the enhanced CFP (ECFP) and YPet
(a variant of YFP) pair [6,31]. According to our experience, the
ECFP/YPet FRET pair allows the development of biosensors with
the significantly enhanced sensitivity [31]. The ECFP and YPet
moieties were linked by a specially selected peptide sequence that
was highly sensitive to furin proteolysis [26,32]. Experimental
evidence demonstrated that, as a result, we developed a highly
selective and sensitive furin biosensor which, in contrast to the
fluorescent peptide substrates, allowed continuous and accurate
monitoring of furin activity both on tumor cell surfaces and in
tumor cell extracts.
The use of the FRET biosensor in a combination with other
analytical methods determined the presence of exceedingly low
levels of active furin on the cancer cell surface. In contrast to the
previous concept, our results suggest that anthrax PA83 is
processed by the furin activity in the extracellular milieu rather
than directly on the cell surface. This parameter provides an
opportunity for the design of anthrax inhibitors which would
inactivate extracellular furin without interfering with normal
physiological functions of cellular furin and furin-like PCs.
Materials and Methods
Materials
Reagents were purchased from Sigma-Aldrich unless indicated
otherwise. The fluorescent substrate pyroglutamic acid-Arg-Thr-
Lys-Arg-methyl-coumaryl-7-amide (Pyr-RTKR-AMC) was from
Peptides International. The furin inhibitor decanoyl-Arg-Val-Lys-
Arg-chloromethylketone (dec-RVKR-cmk) was from Bachem.
Aprotinin was purchased from Serological Corporation. Anthrax
PA83 was purchased from List Biological Laboratories. Human
myelin basic protein (18.5 kDa isoform) was from Biodesign. The
pET directional TOPO Expression kit was obtained from
Invitrogen. The Fugene HD transfection reagent was from Roche
Diagnostics. The murine MON-148 monoclonal antibody against
the catalytic domain of furin was from Axxora. A rabbit polyclonal
GFP antibody that cross-reacts with ECFP and YPet was from
Abcam. The peroxidase-conjugated donkey anti-mouse and anti-
rabbit IgGs were from Jackson ImmunoResearch Laboratories.
The NS2B-NS3 proteinase from West Nile virus (WNV) was
purified as reported earlier [33].
Cloning and plasmid construction
The ECFP-YPet FRET biosensor (GenBank Accession
#EU545473) in the pRSETb vector was initially designed for
monitoring the activity of membrane type-1 matrix metallopro-
teinase [6]. This construct was used as a template for constructing
the furin biosensor. The SNSRKKRQSTSAGP sequence of
anthrax PA83 was inserted by the PCR mutagenesis in the ECFP-
YPet construct using the 59-AGCAACAGCCGTAAAAAAC-
GTAGTACTAGTGCCGGCCCGATGGTGAGCAAGGGCG-
AGGAG-39 and 59- CGGGCCGGCACTAGTACTACGTTT-
TTTACGGCTGTTGCTGAGCTCTTTGTACAATTCATT-39
oligonucleotides as the forward and reverse primers, respectively
(the sequence coding for the furin cleavage site is underlined). The
amplified sequence was inserted into the pET101/D-TOPO
expression vector (Invitrogen) and N-terminally tagged with the
Hisx6 and FLAG tags. The authenticity of the constructs was
confirmed by DNA sequencing. The constructs encoding the full-
length human furin (furWT) and the catalytically inert furin
mutant D153N (furD153N) in which Asn replaced the essential
active site Asp153 were described earlier [34]. The furin constructs
were sub-cloned into the pcDNA 3.1/V5-His-TOPO vector.
Cells
Human glioma TP98G, U373 and U251, fibrosarcoma
HT1080, breast carcinoma MCF-7 and colon carcinoma LoVo
cells (all from ATCC, Manassas, VA) were grown in DMEM
supplemented with 10% fetal bovine serum (FBS) and penicillin-
streptomycin (100 units/ml and 100 mg/ml, respectively). Sub-
confluent MCF-7 and LoVo cells (2610
5 and 5610
5, respectively)
were transfected using Fugene HD reagent (3 ml/1 mg DNA).
MCF-7 and LoVo cells were transfected with the furWT and
furD153N constructs to obtain the stably transfected MCF-
7:furWT, MCF-7:furD153N and LoVo:furWT cells. Transfected
cells were grown for 3–4 weeks in the presence of G418 (1 mg/ml).
Cell clones with the high expression of furin were identified using
Western blotting with the furin MON-148 antibody. Glioma U251
cells stably transfected with a1-anti-trypsin variant Portland (a
potent inhibitor of furin; PDX) were constructed and character-
ized earlier (U251/PDX cells) [35,36].
Furin biosensor expression and purification
The biosensor construct was expressed in E. coli BL21 (DE3)
Codon Plus cells. The expression of the construct was induced for
16 h at 30uC using 1 mM isopropyl b-D-thiogalactoside. The cells
were collected by centrifugation and disrupted by sonication on ice
in 20 mM Tris-HCl buffer, pH 8.0, containing 200 mM NaCl, a
proteinase inhibitor cocktail and lysozyme (5 mg/ml). The
biosensor was purified from the supernatant fraction using a
HiTrap Co
2+-chelating Sepharose FastFlow 1.662.5 cm size
column (GE Healthcare) equilibrated with 20 mM Tris-HCl
buffer, pH 8.0, containing 200 mM NaCl. The biosensor was
eluted using a 25–500 mM gradient of imidazole concentrations in
20 mM Tris-HCl buffer, pH 8.0, containing 200 mM NaCl. The
peak fractions were combined, dialyzed against 100 mM Hepes,
pH 7.5, containing 150 mM NaCl, 1 mM CaCl2, and 1 mM
MgCl2, and frozen at 280uC until use.
Furin expression and purification
The expression of the soluble C-terminally truncated furin
construct in Sf9 insect cells (an ovarian cell line from fall
FRET Biosensor of Furin
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baculovirus and purification of furin were described earlier [34].
FRET assay
The biosensor (100 pmol; 6 mg) was co-incubated for 15–
240 min with purified furin (10–100 fmol; 0.6–6 ng) at 37uCi n
0.1 ml of the assay buffer (100 mM Hepes, pH 7.5, containing
150 mM NaCl, 1 mM CaCl2 and 1 mM MgCl2) in a well of a 96-
well plate. The emission ratio of ECFP/YPet (476 nm/526 nm) at
lex=437 nm was measured by a fluorescence plate reader
(FlexStation3, Molecular Devices) to assess the FRET efficiency
between ECFP (serving as a donor) and YPet (serving as an
acceptor).
Cleavage of protein substrates
The cleavage reactions (22 ml each) were performed in 100 mm
HEPES, pH 7.5, containing 1 mm CaCl2,1m mb-mercaptoeth-
anol and 0.005% Brij35 (for furin) and 10 mM Tris-HCl, 8.0
containing 20% glycerol (for WNV NS2B-NS3 proteinase). The
ECFP/YPet biosensor and PA83 (20 pmol each) were each co-
incubated for 1 h at 37uC with the proteinases at a 1:1-1:10,000
enzyme-substrate molar ratio. The cleavage reactions were
stopped using 1% SDS. The digests were analyzed by SDS-gel
electrophoresis followed by Coomassie staining. Where indicated,
aprotinin and dec-RVKR-cmk (at a 1:4-1:1,100 and a 1:20
enzyme-inhibitor molar ratio, respectively) were added to the
reactions.
Cleavage of the biosensor by cell samples
Cells (5610
4) in DMEM-10% FBS were seeded in wells of a 96-
well plate for 24 h. After washing, 0.1 ml 100 mM Hepes, pH 7.5,
supplemented with 150 mM NaCl, 1 mM CaCl2, and 1 mM
MgCl2, 1% insulin-transferrin-selenium liquid supplement (ITS)
and the biosensor (100 pmol, 6 mg) were added to the cells. After
incubation for 2–16 h, the emission ratio of ECFP/YPet (476 nm/
526 nm) at lex=437 nm was measured using a FlexStation3
fluorescence plate reader.
For the cleavage of the biosensor by the cell lysates, the cells
were detached using 2% EDTA in PBS. After washing, cells were
collected by centrifugation and lysed for 1 h at 4uC in 100 mM
Hepes, pH 7.5, supplemented with 150 mM NaCl, 1 mM CaCl2,
1 mM MgCl2 and 0.1% Triton X-100. The cell lysates (50 mg
total protein) were co-incubated for 2 h at 37uC with the biosensor
(100 pmol, 6 mg). The emission ratio of ECFP/YPet (476 nm/
526 nm) at lex=437 nm was measured using a FlexStation3
fluorescence plate reader. The samples were also analyzed by
Western blotting with the anti-GFP antibody.
Processing of PA83 by the cells
PA83 was labeled for 30 min at 4uC using EZ-Link sulfo-NHS-
LC-biotin (Pierce; a 1:20 protein-biotin molar ratio). Excess biotin
was removed using a 0.7-ml spin-column. Where indicated, biotin-
labeled PA83 (bPA83) was co-incubated with furin (at a 1:100
enzyme-substrate molar ratio) to convert bPA83 into biotin-
labeled PA63 (bPA63). U251, LoVo-mock and LoVo:furWT cells
(3610
5) were each incubated for 3 h at 37uC in DMEM
supplemented with 25 mM HEPES, pH 7.0, 0.2% BSA and
bPA63 or bPA83 (1 mg/ml). Where indicated, dec-RVKR-cmk
(25 mM) and aprotinin (100 mM) were added to the cells 20 min
before adding bPA83/bPA63. After incubation, cells were lysed in
50 mM octyl-b-D-glucopyranoside (Amresco) in TBS supplement-
ed with 1 mM CaCl2, 1 mM MgCl2, a protease inhibitor mixture
set III, 1 mM phenylmethylsulfonyl fluoride (PMSF) and dec-
RVKR-cmk (5 mM). To measure cell-associated bPA83 and
bPA63, the samples were analyzed by Western blotting with
horseradish peroxidase-conjugated ExtrAvidin and a TMB/M
substrate (Chemicon). Where indicated, cells were washed for
3 min in 50 mM glycine-100 mM NaCl, pH 3.0, to remove cell
surface-associated bPA83/bPA63. The samples were then neu-
tralized using 500 mM Hepes-100 mM NaCl, pH 7.5 [37].
Cell surface biotinylation
Cells (15610
6; 90% confluent) were washed twice with an ice-
cold Soerensen Buffer (SBS), pH 7.8, containing 14.7 mm
KH2PO4, 2 mm Na2HPO4, and 120 mm sorbitol, and then
incubated for 10 min in ice-cold SBS. Cell surface-associated furin
was biotinylated by incubating cells for 25 min on ice with SBS
supplemented with membrane-impermeable EZ-Link NHS-LC-
biotin (0.3 mg/ml). Excess biotin was removed by washing the
cells in SBS. The residual amounts of biotin were quenched by
incubating the cells for 10 min in SBS-100 mm glycine. Quenched
cells were lysed in 50 mm N-octyl-b-d-glucopyranoside in 50 mM
Tris-HCl, pH 7.4, supplemented with 150 mM NaCl, 1 mm
CaCl2, 1 mm MgCl2, a proteinase inhibitor cocktail set III, 1 mm
PMSF and 10 mM dec-RVKR-cmk. Biotin-labeled furin was
precipitated from the cell lysates using streptavidin-agarose beads.
The precipitated samples were analyzed by Western blotting with
the MON-148 furin antibody followed by donkey anti-mouse IgG-
conjugated with horseradish peroxidase and a SuperSignal West
Dura Extended Duration Substrate kit (Pierce).
Peptide substrate cleavage
The cleavage reactions (200 ml each) were performed in
100 mm HEPES, pH 7.5, containing 1 mm CaCl2,1 m mb-
mercaptoethanol and 0.005% Brij-35 (for furin) and 10 mM Tris-
HCl, 8.0 containing 20% glycerol (for WNV NS2B-NS3
proteinase). Pyr-RTKR-AMC (25 mM) was used as a substrate.
The assays were performed in triplicate in wells of a 96-well plate.
The steady-state rate of substrate hydrolysis was monitored
continuously at lex=360 nm and lem=465 nm at 37uC using a
fluorescence plate reader.
Cell viability assay
Cells (5610
4) were grown in DMEM-10% FBS for 16 h in wells
of a 96-well plate. After washing, the cells were incubated for 2–
4 h in 100 mM Hepes, pH 7.5, supplemented with 150 mM
NaCl, 1 mM CaCl2, 1 mM MgCl2 and 1% ITS. Cell viability was
determined using an ATP-Lite kit (Perkin-Elmer). The resulting
luminescence was measured using a plate reader (SpectroFluor
Plus, Tecan). Each datum point represented the results of at least
three independent experiments performed in triplicate.
Antibody uptake and immunofluorescence microscopy
Cells were seeded on 13 mm round glass coverslips and grown
at 37uC until a 50% confluence. Cells were then washed in PBS,
fixed with 4% paraformaldehyde for 15 min, and permeabilized
for 4 min using 0.1% Triton X-100. Cells were blocked with 3%
BSA and incubated for 16 h at 4uC with the primary antibodies
(dilution 1:1,000-1:1,500) followed by an 1 h incubation with the
secondary species–specific IgG conjugated with Alexa Fluor 488 or
Alexa Fluor 594 (Molecular Probes). The slides were mounted in
the VectaShield anti-fading embedding medium (Vector Labora-
tories) containing 49,6-diamidino-2-phenylindole (DAPI) for the
nuclear staining.
In the antibody uptake experiments, cells were incubated for
15 min at 4uC in the serum-free, L-15 medium supplemented with
FRET Biosensor of Furin
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with the MON-148 furin antibody (10 mg/ml). After washing with
ice-cold PBS, the cells were next transferred to 37uC for 1 h to
stimulate the antibody uptake. Following fixation and permeabi-
lization as above, the cells were stained for 1 h using the Alexa
Fluor 594-conjugated secondary antibody, mounted in the
VectaShield medium. Images were acquired using a6400 original
magnification on an Olympus BX51 fluorescence microscope
equipped with an Olympus MagnaFire digital camera and
MagnaFire 2.1C software.
Results
Biosensor design, expression and purification
According the observation by us and others, anthrax PA83 is
one of the most sensitive cleavage targets of furin and related PCs
[26,32,38,39]. Because the substrate cleavage preferences overlap
significantly between furin and other PCs, we refer to furin for
simplicity in the text below.
The cleavage of PA83 and its conversion into the N-terminal
PA20 and the C-terminal PA63 fragment is a result of the cleavage
of the SNSRKKRQSTSAGP sequence by furin [21]. To design
an ECFP-YPet biosensor which would be both sensitive to the
cleavage by furin and suitable for the FRET-based monitoring of
its activity, the C-terminus of YPet and the N-terminus of ECFP
were linked by the SNSRKKRQSTSAGP sequence of PA83. To
facilitate the isolation of the ECFP-YPet biosensor from the
recombinant cells, the construct was N-terminally tagged with the
FLAG and Hisx6 tags and expressed in E.coli. After induction with
isopropyl b-D-thiogalactoside, the biosensor was produced as a
soluble protein. After disruption of E.coli cells by sonication, the
soluble protein fraction was loaded onto a Co
2+-agarose affinity
column. The biosensor protein was eluted with a gradient of
imidazole concentrations (Fig. 1).
The biosensor is cleaved by furin
It is expected that furin would cleave the
SNSRKKRQSTSAGP linker sequence and separate YPet and
ECFP. These events will decrease FRET and, concomitantly,
increase the emission ratio of ECFP/YPet. In agreement,
following co-incubation of the biosensor with furin, a decrease in
both FRET and the YPet emission was recorded. These events
were concomitant with an increase in the ECFP emission. Both the
concentration-dependent and time-course studies were consistent
with the ratiometric and directly proportional response of the
biosensor to furin proteolysis. The levels of furin as low as 10 fmol
were sufficient to cause the measurable changes in the ECFP/YPet
ratio (Fig. 2).
We determined that the biosensor and PA83 were similarly
sensitive to furin proteolysis (Fig. 3). There were no cleavage sites
in the biosensor additional to the linker and, as a result, only the
cleavage products that corresponded to the ECFP and YPet
moieties were observed in the digest reactions. Similar to PA83,
the biosensor was sensitive to the in vitro proteolysis by PACE4,
PC1/3, PC2, PC4, PC5/6 and PC7 (data not shown). In turn,
both PA83 and the biosensor were resistant to the proteolysis by
WNV NS2B-NS3 proteinase regardless that the latter exhibits the
furin-like, albeit less stringent, cleavage preferences [33,40,41]. In
contrast, NS2B-NS3 proteinase and furin were similarly efficient
in the cleavage of the fluorescent Pyr-RTKR-AMC peptide
substrate (Fig. 4). From these perspectives, the biosensor appeared
to be selective for furin and furin-like PCs.
Figure 1. The biosensor and its purification. Left panel, the ECFP/YPet construct was N-terminally tagged with the Hisx6 and FLAG tags. The
furin cleavage sequence (SNSRKKRQSTSAGP) of anthrax PA83 was inserted between the N-terminal Met of ECFP and the C-terminal Leu of YPet. Right
panel, SDS-gel electrophoresis of the elution fractions of the biosensor purified by Co
2+-chelating chromatography.
doi:10.1371/journal.pone.0011305.g001
Figure 2. Characterization of the biosensor. Left panel, the emission spectra (lex=437 nm) of the purified biosensor (100 pmol) before and after
its cleavage for 1 h at 37uC using purified furin (10 fmol and 100 fmol). RFU, relative fluorescence unit. Middle panel, the time course of the ECFP/YPet
emission ratio (476 nm/526 nm at lex=437 nm) of the biosensor (100 pmol) incubated for 4 h at 37uC with or without furin (10 fmol and 100 fmol).
Right panel, a ratiometric response of the normalized ECFP/YPet emission ratio to the increasing concentrations of furin. Incubation time, 1 h. These
experiments were repeated multiple times with similar results. The representative experiments are shown.
doi:10.1371/journal.pone.0011305.g002
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Because of its significant, 500-residue, size, the biosensor is
incapable of penetrating the plasma membrane efficiently. As a
result, we initially used the biosensor to assess cell surface-
associated furin in fibrosarcoma HT1080, breast carcinoma MCF-
7, and glioma TP98G, U373 and U251 cells, which naturally
express different levels of furin and also in colon carcinoma LoVo
cells. Because of the two frame-shift mutations in the furin gene,
LoVo cells do not express functionally active furin [42]. We also
used MCF-7 cells which were stably transfected with either the
wild-type furin (MCF-7:furWT) or the catalytically inert furin
mutant (MCF-7:furD153N) and LoVo cells with the reconstituted
expression of the wild-type furin (LoVo:furWT).
The activity of cellular furin was readily recorded by using the
biosensor. A short, 2-h incubation was sufficient for recording
furin activity in MCF-7:furWT cells while 8–16 h were required in
the cells which express furin naturally. Because of the expression of
the catalytically inert furin, both MCF-7:furD153N and LoVo
cells did not activate the biosensor. The naturally expressed furin
activity was the most prominent in U251 and HT1080 cells (Fig. 5).
Based on the ratiometric response curve that shows the
normalized ECFP/YPet emission ratio of the biosensor co-
incubated for 1 h with the increasing concentrations of purified
furin (20–100 fmol) (Fig. 2) and on the data of Fig. 6 that show the
normalized ECFP/YPet emission ratio of the biosensor co-
incubated for 0.5–4 h with 5610
4 MCF-7:furWT cells, it is
possible to estimate the number of active furin molecules per cell.
Thus, the net activity of furin in 5610
4 MCF-7:furWT cells
roughly corresponded to 10 fmol (,0.6 ng) furin or ,100,000
furin molecules/cell. The level of furin in U251 cells was several-
fold lower (Fig. 5). The electrophoretic analysis confirmed the
specific cleavage of the biosensor by MCF-7:furWT and U251
cells. The predominant cleavage products correlated with the
expected ECFP and YPet moieties (Fig. 6).
Low levels of cell surface furin
Western blotting analysis demonstrated that it was difficult to
unambiguously detect furin in cell lysates unless the cells with the
enforced expression of furin were used (Fig. 7). To determine the
levels of cell surface-associated furin, cells were surface-biotiny-
lated using membrane-impermeable biotin. Biotin-labeled proteins
were precipitated using the streptavidin-agarose beads. The
resulting samples were analyzed by Western blotting with the
MON-148 furin antibody. Surprisingly, despite high amounts of
the loaded protein material, which corresponded to 12610
6cells/
lane, exceedingly low levels of furin were detected in the biotin-
labeled MCF-7:furWT cell samples (Fig. 7).
To corroborate these data, we next used the furin antibody
uptake. For these purposes, U251 cells and MCF-7:furWT, which
express low and high level of furin, respectively, were allowed to
bind the MON-148 antibody for 1 h at 4uC. After washings to
remove the unbound antibody, the cells were moved to 37uCt o
stimulate the internalization of the cell surface-associated furin-
antibody complex. The cells were next fixed, permeabilized and
stained with a secondary antibody to determine the sub-cellular
localization of the furin-antibody complex. We, however, did not
Figure 3. The biosensor is cleaved by furin but it is resistant to WNV NS2B-NS3 proteinase. Left panels, the biosensor and PA83 were
cleaved by furin (1 h; 37uC) at the indicated enzyme-substrate ratio. Right panel, the biosensor was cleaved by WNV NS2B-NS3 proteinase (1 h; 37uC)
at the indicated enzyme-substrate ratio. The cleavage reactions were analyzed by SDS-gel electrophoresis followed by Coomassie staining.
doi:10.1371/journal.pone.0011305.g003
Figure 4. The similar activity of furin and WNV NS2B-NS3 proteinase against Pyr-RTKR-AMC. Both furin and WNV NS2B-NS3 proteinase
(0.2-4 pmol each) were allowed to cleave the fluorescent peptide for the indicated time. RFU, relative fluorescence unit.
doi:10.1371/journal.pone.0011305.g004
FRET Biosensor of Furin
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was no detectable level of furin on the cell surface (Fig. 8A).
We next use direct immunostaining of the permeabilized MCF-
7:furWT and MCF-7 (control) cells with the MON-148 antibody.
The presence of the intracellular furin was readily recorded in
MCF-7:furWT cells. Co-staining of MCF-7:furWT cells using the
MON-148 furin antibody and the TGN46 antibody (a trans-Golgi
network marker) demonstrated the presence of furin in the trans-
Golgi network and in the intracellular vesicles in the permeabilized
cells (Fig. 8B). The staining of MCF-7 cells was clearly negative.
Non-permeabilized cells also did not show any furin immunore-
activity in the intracellular compartment and at the cell surface
(not shown). Overall, the significant levels of cell surface-furin we
detected using the biosensor did not correlate with the results of
our other studies.
Proteinases distinct from furin do not cleave PA83
Based on our data, we tested if cellular serine proteinases with
PC-like specificity, but distinct from PCs, contributed to the
cleavage of both PA83. To exclude this possibility, we used
aprotinin, a potent inhibitor of trypsin-like proteinases, in the in
vitro and cell-based cleavage tests. Even exceedingly high levels (at
a 1:1000 enzyme-inhibitor molar ratio) of aprotinin did not affect
the PA83-converting activity of furin in the cleavage reactions in
vitro. In contrast, furin activity was fully repressed by its specific
inhibitor, dec-RVKR-cmk (ki=1 nM), at a low, 1:20, enzyme-
inhibitor molar ratio. Consistent with its inhibitory specificity,
aprotinin (a nanomolar range inhibitor of WNV NS2B-NS3
proteinase; ki=26 nM) [33,43] blocked this proteinase activity at a
low, 1:20, enzyme-inhibitor molar ratio. Because PA83 is resistant
to the viral proteinase, the activity of the latter was determined
using myelin basic protein as a substrate (Fig. 9) [33].
We next examined if aprotinin and dec-RVKR-cmk affected
the proteolytic processing of PA83 in U251 and LoVo:furWT
cells. For this purposes, bPA83 was co-incubated with either the
intact cells or with the cells co-incubated with aprotinin or dec-
RVKR-cmk. The amounts of cell-associated bPA83 and bPA63
were determined by Western blotting. The results showed intact
U251 and LoVo:furWT cells readily processed the external
bPA83. Because of the binding to the anthrax toxin receptor,
bPA63 and the residual amounts of intact bPA83 were detected in
cell extracts. Dec-RVKR-cmk (25 mM) caused a near complete
inhibition of bPA83 in U251 cells. In turn, aprotinin (100 mM) did
not show any effect (Fig. 10A). As a result, we concluded that cell
surface-associated proteinases distinct from furin-like PCs, did not
significantly contribute to the processing of PA83. Because cell-
surface levels of furin are exceedingly low (Fig. 7 and 8), these data
also suggest that PA83 is cleaved by furin in the extracellular
milieu but not on the cell surface, and that the resulting PA63
would be capable of binding with the cells. Thus, our earlier data
directly indicate that the levels of furin in fibrosarcoma HT1080
and glioma U251 cells are sufficient to sustain efficient anthrax
toxin intoxication [44].
Both PA83 and PA63 bind the anthrax toxin receptor
To test this suggestion, U251 cells were allowed to bind the
equal amounts of bPA83 and of the pre-made bPA63. To generate
bPA63, bPA83 was fully processed in the in vitro cleavage reactions
using the purified furin (Fig. 10B). The levels of the uptake of
bPA83 and bPA63 by the cells were determined using Western
blotting of the cell lysates. bPA83 and bPA63 were equally
efficiently internalized by the cells. Dec-RVKR-cmk inhibited the
processing and uptake of bPA83 by the cells. The inhibitor did not
affect the processing and uptake of bPA63. Acid treatment of the
cells demonstrated the efficient removal of the cell surface-bound
bPA83 while there was no similar effect with bPA63 (Fig. 10B).
Taken together, these results indicated that bPA83 was not
processed at the cell surface in our cell system. Conversely, these
results suggested that bPA83 was processed in the extracellular
milieu and that only then the generated bPA63 associated with the
anthrax toxin receptor in the cells. These parameters suggested the
Figure 5. Activation of the biosensor by cellular furin. Adherent
glioma TP98G, U373 and U251 cells, fibrosarcoma HT1080 cells, colon
carcinoma LoVo cells and breast carcinoma MCF-7, MCF-7:furD153N
and MCF-7:furWT cells (5610
4) were co-incubated for 2–16 h with the
biosensor (100 pmol).
doi:10.1371/journal.pone.0011305.g005
Figure 6. Activation and cleavage of the biosensor by cellular furin. Left panel, the time course of the biosensor cleavage by U251, MCF-
7:furWT and MCF-7:fur:D153N cells (5610
4). Right panel, SDS-gel electrophoresis of the cleavage reactions. Cells (5610
4) were incubated for 4 h with
the biosensor (100 pmol). After centrifugation, the supernatant samples were separated by SDS-gel electrophoresis followed by Coomassie staining.
Purified furin (10 fmol and 100 fmol) was used as a control.
doi:10.1371/journal.pone.0011305.g006
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contributed to the measurements in our biosensor cleavage tests.
Intracellular furin pool interfered with the biosensor
cleavage
To test if our suggestion was correct, we incubated the biosensor
with the adherent MCF-7:furWT and U251 cells. We then
determined the normalized ECFP/YPet emission ratio in the
supernatant samples (Fig. 11A). In addition, we incubated the cells
alone in the assay buffer. We then tested if the supernatant fraction
that contained the released cellular proteins was capable of
cleaving the biosensor. These tests suggested that the efficiency of
the biosensor cleavage by the adherent cells and by the soluble
proteins released by the cells was very similar. It appeared that
there was a significant release of intracellular furin and,
potentially, additional PCs by the cells because the cells did not
survive well under our experimental conditions. In agreement, we
detected a significant level of apoptosis in the cells. Cell viability
tests revealed that 30–35% cells became apoptotic in the course of
a short, 4-h, incubation time and that the cell realizate rather than
cell surface-associated furin alone contributed to the biosensor
cleavage (Fig. 11B). On the other hand, these results also suggested
that the cell-impermeable biosensor can be efficiently used to
quantify the total cell furin in the cell lysate samples rather than
cell surface-associated furin alone using the intact cells.
The biosensor quantifies total cellular furin in cancer cell
lysates
Normally, detergents, including Triton X-100, are required for
disrupting the cell membrane and for cell protein solubilization.
First, we confirmed that the presence of 0.1% Triton in the
reactions did not affect the efficiency of the biosensor cleavage by
purified furin as determined by both the measurement of the
ECFP/YPet ratio and the SDS-gel electrophoresis of the digest
samples and (Fig. 12).
We then prepared the total lysates of MCF-7, MCF-7:furWT,
MCF-7:furD153N, LoVo, LoVo:furWT, U251 and U251/PDX
cells using 0.1% Triton X-100. Following centrifugation to remove
the insoluble material, the supernatant aliquots were directly used
to cleave the biosensor. Dec-RVKR-cmk was used to inhibit furin
in the cleavage reactions. The lysates of MCF-7, MCF-
7:furD153N, LoVo and U251/PDX cells did not cleave the
Figure 7. Analysis of cellular furin. Left panel, Western blotting of total cell furin (15 mg total protein that corresponded to 5-7610
4 cells
depending on a cell type). Right panel, Western blotting of cell surface-associated furin. MCF-7 and MCF-7:furWT cells (15610
6) were cell surface
biotinylated using membrane-impermeable biotin. Biotin-labeled furin was immunoprecipitated from the total cell lysate (TCL) using streptavidin-
agarose beads. The beads were washed in 50 mM Tris-HCl, pH 7.4, supplemented with 50 mm N-octyl-b-d-glucopyranoside, 150 mM NaCl, 1 mm
CaCl2, 1 mm MgCl2, a proteinase inhibitor cocktail set III, and 1 mm PMSF (FT, flow through fraction). The immunocaptured proteins (IP,
immunoprecipitated protein fraction) were eluted using 1% SDS. The fractions were analyzed by Western blotting with the furin MON-148 antibody
followed by donkey anti-mouse IgG-conjugated with horseradish peroxidase and a SuperSignal West Dura Extended Duration Substrate kit. The gels
were overexposed to demonstrate the presence of cell-surface furin. Right lane, purified furin (1 ng). WB, Western blotting.
doi:10.1371/journal.pone.0011305.g007
Figure 8. Furin is expressed in the trans-Golgi network in MCF-
7:furWT cells. A, left panels, the uptake of the MON-148 furin antibody did
not reveal cell surface furin in U251 and MCF-7:furWT cells. Cells were
allowed to bind the antibody at 4uC. Cells were then incubated at 37uCt o
stimulate the antibody uptake, fixed, permeabilized and stained with the
Alexa Fluor 594-conjugated secondary antibody (red). Right panels, staining
of cellular furin. Cells were fixed, permeabilized and stained using the MON-
148 antibody followed by the Alexa Fluor 594-conjugated secondary
antibody. B, MCF-7:furWT and MCF-7 cells were fixed, permeabilized and
stained using the rabbit polyclonal TGN46 antibody (green) and the MON-
148 furin antibody (red). The merged panelsshow the level of co-localization
o ff u r i nw i t hT G N 4 6( at r a n s - G o l g in e t w o rk marker). Original magnification
6400; the bar, 10 mm. The nuclei were stained with DAPI (blue).
doi:10.1371/journal.pone.0011305.g008
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PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e11305Figure 9. Aprotinin inhibits WNV NS2B-NS3 proteinase activity but not furin. PA83 (1 mM) and myelin basic protein (MBP; 11 mM) were
incubated for 1 h at 37uC with furin (1–10 nM; 1:100-1:1,000 enzyme-substrate molar ratio) and WNV NS2B-NS3 proteinase (1.25 mM; 1:10 enzyme-
substrate molar ratio) in the presence of the indicated enzyme-inhibitor molar ratio.
doi:10.1371/journal.pone.0011305.g009
Figure 10. Specific processing of PA83 by cellular furin. A, LoVo:furWT and U251 cells were co-incubated for 3 h at 37uC with bPA83 (1 mg/
ml). Where indicated, cells were pre-incubated for 20 min with dec-RVKR-cmk (25 mM) or aprotinin (100 mM) prior to the addition of bPA83. Cell
lysates were examined using Western blotting with horseradish peroxidase-conjugated ExtrAvidin and a TMB/M substrate. B, left panel, U251 cells
were incubated for 3 h at 37uC with bPA83 (1 mg/ml) with or without dec-RVKR-cmk (25 mM). Where indicated, cells were exposed to the acid pH
treatment to remove the cell surface-associated bPA83 and bPA63. Right panel, conversion of bPA83 into bPA63 using purified furin. The gels were
stained with Coomassie. WB, Western blotting. NS, non-specific band.
doi:10.1371/journal.pone.0011305.g010
Figure 11. Furin activity was released by the cells. A, the time course of the biosensor cleavage by cell realizate and by adherent MCF-7:furWT
and U251 cells. Cells (5610
4) were incubated for 2 h in 100 mM Hepes, pH 7.5, containing 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2 and 1% ITS. The
cells were then separated by centrifugation and the supernatant (realizate) was co-incubated with the biosensor for 0–120 min. Alternatively,
adherent cells (5610
4) were directly co-incubated with the biosensor. B, ATP-Lite cell viability assay. Prior to the assay, MCF-7, MCF-7:furWT and U251
cells were incubated for 2–4 h at 37uC in 100 mM Hepes, pH 7.5, containing 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2 and 1% ITS. The level of induced
apoptosis was then determined using an ATP-Lite kit.
doi:10.1371/journal.pone.0011305.g011
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in MCF-7:furWT, LoVo:furWT and U251 cells. Dec-RVKR-cmk
fully suppressed the cleavage of the biosensor in these cells (Fig. 13).
According to the calibration curve with purified furin (Fig. 2) and
the cleavage data using cell lysates, the net levels of furin were 109
fmol, 43 fmol and 24 fmol in MCF-7:furWT, LoVo:furWT and
U251 cells, respectively. It is, however, probable that other PCs
also contributed to the biosensor cleavage, especially in U251 cells.
In contrast with the biosensor, the fluorescent Pyr-RTKR-AMC
peptide substrate cannot be employed with the crude cell samples.
Indeed, when Pyr-RTKR-AMC was used, the lysates of U251 and
U251/PDX cells were similarly efficient in cleaving Pyr-RTKR-
AMC despite the drastically different levels of their furin activity.
Similarly, there was no significant difference between of the MCF-
7, MCF-7:furWT and MCF-7:furD153N samples if Pyr-RTKR-
AMC was used (Fig. 14A).
To confirm further that other cellular proteinases which are
distinct from PCs did not significantly contribute to the biosensor
cleavage, the latter was co-incubated with the totals cell lysates of
MCF-7:furWT, LoVo:furWT and U251 cells. The digest samples
were then analyzed using Western blotting with a GFP antibody
(Fig. 14B). The data confirmed the specific cleavage of the
biosensor by the MCF-7:furWT, LoVo:furWT and U231 samples.
Dec-RVKR-cmk fully repressed the cleavage. Other cell types did
not cleave the biosensor efficiently suggesting that cellular
proteinases distinct from furin-like PCs did not contribute
significantly to the biosensor cleavage.
Discussion
Multiple physiologically-relevant proteins are synthesized as
latent precursors [14,45]. These precursors are transformed into
active proteins by the cleavage action of furin and related PCs
[16]. Furin is also implicated in the processing of many pathogens
including anthrax [16,21,26,38,39]. Furin itself is self-activated
[21], and upon activation it cleaves de novo synthesized latent
precursors in the Golgi compartment and in the secretory vesicles.
It was believed that some proportion of the furin molecules cycles
between the trans-Golgi compartment and the cell surface, albeit
the presence of cell-surface furin was never convincingly
demonstrated [46]. Because of the overlapping substrate prefer-
ences, there is a redundancy in the PC functionality, albeit
distinctive functions of furin have also been reported [47].
Evidence suggests that in multiple cancer types furin overex-
pression causes an imbalance in the activation of invasion- and
proliferation-related cellular substrates leading to acquisition of an
advanced malignant phenotype [48,49,50,51,52]. The multiple
effects of furin on cell function have led to a concept that in the
course of tumor development and progression furin acts as ‘‘a
master switch’’ of the tumorigenic protein functionality. If this
concept is valid, furin then could be identified as an important
therapeutic target in a number of cancer types. The sensitive and
selective read-out technology to reliably monitor furin activity in
cells and tissues, however, is not currently available. The absence
of a reliable read-out does not allow correlating furin activity with
Figure 12. The biosensor cleavage in cell lysates. Left panel, Triton X-100 (0.1%) does not affect the efficiency of furin proteolysis of the
biosensor. The biosensor was co-incubated with purified furin (5 fmol and 50 fmol) for 0-120 min with or without 0.1% Triton X-100. Right panel, the
biosensor was co-incubated 1 h with purified furin at the indicated enzyme-substrate molar ratio. The digests were analyzed by SDS-gel
electrophoresis followed by Coomassie staining. Where indicated, reactions contained 0.1% Triton X-100.
doi:10.1371/journal.pone.0011305.g012
Figure 13. The biosensor allows to measure reliably furin activity in cell lysates. The time course of the biosensor cleavage by the MCF-7,
LoVo and U251 total cell lysates. The cells were lysed for 1 h at 4uC in the buffer containing 0.1% Triton X-100. The insoluble material was discarded
by centrifugation. The supernatant aliquots (50 mg total protein; an equivalent of ,5610
4 cells) were co-incubated for 2 h at 37uC with the biosensor
(100 pmol).
doi:10.1371/journal.pone.0011305.g013
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furin is coordinated in space and time in the cell compartment.
To shed more light on the furin functionality, we designed and
tested a cleavage-activated biosensor to monitor the net activity of
furin. The biosensor represents a chimeric protein in which an
ECFP and YPet FRET pair is linked by a peptide linker sequence
derived from anthrax PA83. We specifically selected this sequence
as a linker because the SNSRKKRQSTSAGP furin cleavage site
of PA83 is supremely sensitive and selective to the proteolysis by
furin and related PCs with the redundant cleavage preferences
[26,32].
The use of the biosensor in a combination with other
methodologies have allowed us to determine that the levels of
cell surface-associated furin are exceedingly low and that they
represent a diminutive fraction of the total cell furin. The detected
minuscule cell-surface furin levels are grossly insufficient to
accomplish the cell-surface processing of anthrax PA83. Our data
directly suggest that, at least in the cell-based systems, PA83 is
processed by furin extracellularly. This processing is followed by
the binding of the resulting PA63 heptamer or the mixed
heptamer that includes both the PA63 and the PA83 subunits to
the anthrax receptors [22,24,29]. Our data shift a long-term
paradigm in the furin biology and anthrax infection [53]. In
addition, these novel results provide an opportunity for a design of
the specific cell-impermeable furin inhibitors of anthrax. These
inhibitors would not interfere with normal cellular function of
furin and related PCs in the trans-Golgi compartment [39].
It is now tempting to hypothesize that the release of the
intracellular furin pool and, probably, other PCs from the already
infected, dying cells is cleverly used by anthrax to support the
further avalanche-like propagation of infection. The use of the
released PCs instead of cell-surface furin eliminates the spatial
constraints that limit the interactions between the membrane-
tethered PA83-anthrax receptor complexes and furin at the cell
surface.
Our tests demonstrated that the biosensor we designed allowed
us to selectively record the cleavage activity using as low as the
femtomol levels of furin. This high level of selectivity and
sensitivity of the biosensor allowed us to detect furin in the tumor
cell lysate samples using as low as thousands of cells, a task that is
not possible to accomplish reliably with conventional fluorescent
peptide substrates. Because serine proteinases distinct from PCs
destroy the biosensor rather than specifically cleave the linker
sequence, they do not significantly interfere with the specific action
by PCs. The availability of the highly sensitive and selective furin
biosensor provides a foundation for the rapid, non-invasive
procedures to monitor furin and related proteinases in cancer
cells and tumor biopsies. Because furin activity is also important
for multiple infectious diseases caused by bacterial and viral
pathogens, we suggest that the furin biosensor is applicable for
monitoring the activity of furin in a wide range of cells and tissues
and in a variety of disease conditions rather than in cancer alone.
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